PharmacoEconomics & Outcomes News

, Volume 799, Issue 1, pp 33–33 | Cite as

Sophisticated models required for immuno-oncology drugs

Clinical study
  • 6 Downloads

Reference

  1. Gibson EJ, et al. Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes. ClinicoEconomics and Outcomes Research 10: 139-154, 18 Mar 2018. Available from: URL: https://doi.org/10.2147/CEOR.S144208 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations